Defining the tumour immune microenvironment underlying chemoradiation resistance in human papillomavirus related head and neck cancer
定义人乳头瘤病毒相关头颈癌放化疗耐药的肿瘤免疫微环境
基本信息
- 批准号:465385
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-03-01 至 2023-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background and Significance:
Human papillomavirus (HPV) related head and neck cancer is the fastest rising cancer in North America. The standard of care treatment is high dose chemotherapy with high dose radiation. This treatment strategy is general effec
背景和意义:
人乳头瘤病毒(HPV)相关的头颈癌是北美增长最快的癌症。标准治疗是高剂量化疗和高剂量放疗。这种治疗策略是普遍有效的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nichols Anthony C其他文献
Nichols Anthony C的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nichols Anthony C', 18)}}的其他基金
Targeted and immuno-therapy to overcome innate and acquired resistance in aggressive MAPK-addicted cancers.
靶向和免疫治疗可克服侵袭性 MAPK 成瘾癌症的先天性和获得性耐药性。
- 批准号:
469037 - 财政年份:2022
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Mechanisms of resistance to cisplatin and radiation in human papillomavirus (HPV) related head and neck cancer
人乳头瘤病毒(HPV)相关头颈癌的顺铂和放射耐药机制
- 批准号:
431688 - 财政年份:2020
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
The Evolution of the Most Lethal Human Malignancy: The Genetic Progression of Anaplastic Thyroid Cancer
最致命的人类恶性肿瘤的进化:甲状腺未分化癌的遗传进展
- 批准号:
357705 - 财政年份:2016
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Mechanisms of resistance and sensitivity to PI3K inhibition in head and neck cancer.
头颈癌对 PI3K 抑制的耐药性和敏感性机制。
- 批准号:
320547 - 财政年份:2015
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
相似海外基金
Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
- 批准号:
MR/Y008545/1 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Research Grant
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
- 批准号:
10649741 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Breaking prolonged sitting with high-intensity interval training to improve cognitive and brainhealth in older adults: A pilot feasibility trial
通过高强度间歇训练打破久坐以改善老年人的认知和大脑健康:一项试点可行性试验
- 批准号:
10742157 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Pursuing REduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER). A randomized feasibility trial
通过锻炼和康复减少 COVID-19 后的疲劳(前言)。
- 批准号:
488941 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial
慢性肾病患者便秘治疗的临床、生化和微生物学效果:初步可行性试验
- 批准号:
10639532 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Cognitive strategy training in Post-COVID-19 Syndrome: A feasibility trial.
COVID-19 后综合症的认知策略培训:可行性试验。
- 批准号:
10712171 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Building a healthbot to help people adhere to their varenicline prescriptions using patient perspectives: a feasibility trial
构建一个健康机器人,从患者的角度帮助人们遵守伐尼克兰处方:可行性试验
- 批准号:
493338 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Development and Feasibility Trial of Online Peer Support for Parents of Gender Diverse Youth
为性别多元化青少年家长提供在线同伴支持的开发和可行性试验
- 批准号:
10664105 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Intravenous Ketamine versus Personalized Accelerated Brain Stimulation in Treatment-Resistant Depression: A Pilot Randomized Feasibility Trial of Rapid-Acting Treatments (IKARE-TRD)
静脉注射氯胺酮与个性化加速脑刺激治疗难治性抑郁症:快速起效治疗的随机试点可行性试验 (IKARE-TRD)
- 批准号:
490031 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Balanced and Empowered EaTing (BEET) in Diabetes: A feasibility trial
平衡与增强饮食(BEET)治疗糖尿病:可行性试验
- 批准号:
10738030 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:














{{item.name}}会员




